Title
Category
Credits
Event date
Cost
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
$0.00
Nearly 40% of adults in the United States are obese: a number that is expected to rise in the near future.  The impacts of obesity are profound, both in terms of increasing cardiometabolic risk as well as exacerbating morbidity and mortality from existing cardiometabolic conditions.  During this symposium, expert faculty will discuss the importance of obesity as a disease, its comprehensive management, and the latest advances in pharmacotherapy for long-term obesity treatment.   
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
$0.00
During this activity, experts will discuss recent data about the cardiovascular and renal benefits with novel non-steroidal MRAs in patients with diabetic kidney disease (DKD), including the FIGARO-DKD trial and FIDELITY analysis, as well as their clinical practice implications.This activity is also part of the DKD Digital Highlights Hub.
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
$0.00
This masterclass is designed to explore the latest advances about the most pertinent domains in interventional cardiology. Multidisciplinary experts will present on comprehensive interventional cardiology topics, including pre-procedural evaluation, pharmacological aspects, coronary intervention, peripheral intervention, structural intervention, and more. Each section will include patient cases and expert panel discussion, which will aim to provide practical approaches to patient management and interpret the latest advances to patient care.
  • CMHC
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
$0.00
Pregnant women with diabetes often require strict glycemic control in order to reduce the possibility of both immediate and long-term maternal and fetal complications, including macrosomia, large or small for gestational age, C-section, neonatal hyperglycemia, and many more. Additional potential maternal complications, like hypoglycemia, retinopathy, ketoacidosis, and preeclampsia can also occur, often having significant consequences.
  • CMHC
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
$0.00
GLP-1 RAs have carved an important role in the management of patients with type 2 diabetes (T2D), not only in glycemic control, but also in reducing cardiovascular and renal risk. The evolving evidence with GLP-1 RA in this setting has led to important studies and guideline changes, all with significant implications for patient management. This interactive infographic activity will walk you through these updates by using high-impact visuals to summarize the evidence, as well as added expert perspectives.
  • LivDerm
  • TME
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
$0.00
Pediatric patients with skin of color (SoC) can be disproportionately affected by a number of dermatologic conditions, including acne vulgaris, atopic dermatitis, and traction alopecia. It is imperative that providers are able to recognize and appropriately treat these conditions in their pediatric SoC patients. Going beyond basic treatment guidelines, there are steps clinicians can be taking to practice cultural sensitivity when treating patients and communicating with parents and caregivers.
  • LivDerm
  • TME
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
$0.00
Atopic dermatitis (AD) is a chronic inflammatory and relapsing cutaneous disease characterized by pruritus, cutaneous inflammation, and transepidermal water loss (Krakowski 2008).  The incidence of AD in industrialized nations has increased by three-fold over a 30-year span, and it is estimated to affect between 15% and 30% of children in industrialized nations (Bieber 2010).  Although most children with AD will “outgrow” the disease, AD has additionally been reported to affect up to 10% of adults, and recent research suggests that AD is under-recognized in this group (Bieber 2010; Silverbe
  • LivDerm
  • TME
  • AAPA Category I CME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
$0.00
Timely and adequate treatment of atopic dermatitis (AD) is essential for helping to promote better long-term outcomes and quality of life. Targeted immunomodulatory agents, based on recent advances in the understanding of AD pathophysiology, represent additional options for long-term control. In particular, Janus kinase (JAK) inhibitors have emerged as a novel mechanism of action for treatment of AD.
  • LivDerm
  • TME
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
$0.00
There is no doubt that clinicians have been exposed to more information about the human gut than ever before, and most practitioners treating skin disorders have had some form of education related to the skin microbiome.
  • CMHC
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
$0.00
Continuous glucose monitoring (CGM) has emerged as a clinically useful tool for the management of patients with type 2 diabetes, as it provides real-time data to better guide glycemic variability, improve glycemic control, as well as reduce the risk of hypoglycemia and hospitalizations.

Pages